In a surprising twist, Timothy Mellon, an heir to a Gilded Age fortune, has been revealed as the mystery donor of $130 million intended to support U.S. military pay during the government shutdown. However, concerns arise over the legality and sufficiency of this donation.
The Pentagon has received a $130 million anonymous donation to cover military salaries amid a government shutdown, but legal experts warn that using these funds without Congress's approval could be unconstitutional. The donation raises serious questions about military funding and oversight.
In a shocking move, the federal government has begun layoffs affecting thousands of employees due to the ongoing shutdown. With various agencies impacted, including Education and Commerce, the unions are pushing back against the legality of these actions.
President Trump's recent announcement about leucovorin's label update opens new doors for autism treatment, especially for those with cerebral folate deficiency. But is it the miracle some parents hope for?
The Trump administration's recent approval of leucovorin as an autism treatment has sparked outrage among experts, with many calling for more research and caution in prescribing this unproven drug.
Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
An 8-year-old boy's life took a dramatic turn as he regained mobility through an experimental treatment for a rare genetic disorder. After months of decline, hope emerged with a pioneering drug that bypasses the genetic mutation.
In an unprecedented medical achievement, a child with a rare genetic disorder receives a customized CRISPR gene therapy, paving the way for future treatments of similar conditions.
A baby diagnosed with a rare genetic disorder has shown remarkable improvement after receiving an experimental gene editing treatment tailored just for him. This groundbreaking therapy offers hope for others with similar conditions.
KJ Muldoon, born with a deadly genetic disorder, received a groundbreaking CRISPR treatment just six months after birth. His remarkable progress showcases the future of personalized medicine for rare diseases.
